Haisco Pharmaceutical Group news

Latest news

• Lilly’s latest China drug deal; Immunovant’s setback in lupus (opens in a new tab)

  Sep 24, 2026

• 
  AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group (opens in a new tab)

  GlobeNewswire · Sep 8, 2026

• 
  Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners (opens in a new tab)

  PR Newswire · Aug 25, 2026

• 
  Nuvectis Stock Surges Around 97% in 3 Months: Here's Why (opens in a new tab)

  Zacks · Aug 19, 2026

• Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights (opens in a new tab)

  Aug 4, 2026

• 
  StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data (opens in a new tab)

  TMX Newsfile · Jul 14, 2026

• 
  Haisco and Nuvectis sign licensing deal for two drugs (opens in a new tab)

  Hospital Management · Jun 24, 2026

• Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications (opens in a new tab)

  Jun 23, 2026

• 
  Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT) (opens in a new tab)

  InvestorsHub · Jun 22, 2026

• 
  Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (opens in a new tab)

  GlobeNewswire · Jun 22, 2026

• 
  Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets (opens in a new tab)

  Simply Wall St. · Jun 7, 2026

• 
  Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets (opens in a new tab)

  Simply Wall St. · Jun 6, 2026

• Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations (opens in a new tab)

  Jun 3, 2026

• 
  Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas (opens in a new tab)

  PR Newswire · Jun 1, 2026

• 
  AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development (opens in a new tab)

  Insider Monkey · Apr 22, 2026

• Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion (opens in a new tab)

  Jan 12, 2026